Notably, HSF1 activity correlates with a higher rate of survival in several cancer types: breast [90], lung [91], prostate [92], colon [93], myeloma [94], pancreas [95] and hepatocellular carcinoma [96]. Here, HSF1 is linked to hepatocellular carcinoma.